AstraZeneca manufacturing error clouds vaccine study results

LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine. A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected. In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said, the vaccine appeared to be 90% effective. In the group that got two full doses, the vaccine appeared to be 62% effective. Combined, the drugmakers said the vaccine appeared to be 70% effective. But the way in which the results were arrived at and reported by the companies has led to pointed questions from experts. The partial results announced Monday are from large ongoing studies in the U.K. and Brazil designed to determine the optimal dose of vaccine, as well as examine safety and effectiveness. Multiple combinations and doses were tried in the volunteers. They were compared to others who were given a meningitis vaccine or a saline shot.

DID RESEARCHERS MEAN TO GIVE A HALF DOSE?

Before they begin their research, scientists spell out all the steps they are taking, and how they will analyze the results. Any deviation from that protocol can put the results in question.

In a statement Wednesday, Oxford University said some of the vials used in the trial didn’t have the right concentration of vaccine so some volunteers got a half dose.

The university said that it discussed the problem with regulators, and agreed to complete the late stage trial with two groups. The manufacturing problem has been corrected, according to the statement. Experts say the relatively small number of people in the low dose group makes it difficult to know if the effectiveness seen in the group is real or a statistical quirk. Some 2,741 people received a half dose of the vaccine followed by a full dose, AstraZeneca said. A total of 8,895 people received two full doses. Another factor: none of the people in the low-dose group were over 55 years old. Younger people tend to mount a stronger immune response than older people, so it could be that the youth of the participants in the low-dose group is why it looked more effective, not the size of the dose. Another point of confusion comes from a decision to pool results from two groups of participants who received different dosing levels to reach an average 70% effectiveness, said David Salisbury, and associate fellow of the global health program at the Chatham House think tank. “You’ve taken two studies for which different doses were used and come up with a composite that doesn’t represent either of the doses,″ he said of the figure. “I think many people are having trouble with that.″

WHY WOULD A SMALLER FIRST DOSE BE MORE EFFECTIVE?

Oxford researchers say they aren’t certain and they are working to uncover the reason. Sarah Gilbert, one of the Oxford scientists leading the research, said the answer is probably related to providing exactly the right amount of vaccine to trigger the best immune response. “It’s the Goldilocks amount that you want, I think, not too little and not too much. Too much could give you a poor quality response as well,” she said. “So you want just the right amount and it’s a bit hit and miss when you’re trying to go quickly to get that perfect first time.” Details of the trial results will be published in medical journals and provided to U.K. regulators so they can decide whether to authorize distribution of the vaccine. Those reports will include a detailed breakdown that includes demographic and other information about who got sick in each group, and give a more complete picture of how effective the vaccine is. Moncef Slaoui, who leads the U.S. coronavirus vaccine program Operation Warp Speed, said Tuesday in a call with reporters that U.S. officials are trying to determine what immune response the vaccine produced, and may decide to modify the As results. AstratraZeneca study in the U.S. to include a half dose. “But we want it to be based on data and science,” he said. Nick Note: Who knows what sins lie in the data. Do you really want a warp speed vaccine? I prefer till i see the test monkey results. That is our friends and neighbors… Let me know how it works out

California’s Massive Number Of New Coronavirus Cases Jumps 17% In 24 Hours, Sets Another Record

As millions of Californians are traveling and gathering for Thanksgiving, the state is experiencing an unprecedented surge in infections and hospitalizations. The state has seen its three highest tallies of new cases ever in the past five days. On Tuesday, the number of new infections was 15,329. That’s down slightly from what was the all time high of 15,442 on Saturday, but Wednesday’s number dwarfed them both at 18,350. That’s a 17% jump in cases in 24 hours and a rise so steep that the state’s line graph for daily cases is nearly vertical.

“Statewide, I don’t think we’ve ever seen hospital admissions increase like we did just over the past 24 hours,” said California Director of Health and Human Services Dr. Mark Ghaly on Tuesday. “I hope but don’t expect that it’s the highest we’ll ever have.”

Ghaly was right. Just 24 hours later, the number of hospitalizations jumped another 5%, with 408 new patients recorded. As Deadline reported Tuesday, the daily number of hospitalizations due to the virus in California had increased 81% in the 14 days prior, to 6,641. Wednesday’s number brought the number of Covid-19 patients hospitalized in the state to 7,049, which is approaching the all-time high of 8,820 hospitalizations seen on July 21.

Ghaly reminded that today’s hospitalizations are the result of the number of infections seen two weeks prior. So Tuesday’s patients are based on a case number of 7,000 that we saw on November 10. Tuesday’s daily new case count was 15,329, more than double that from two weeks ago. “We’re concerned,” said Ghaly about what lies ahead. According to Ghaly and others, Covid-19-related hospitalizations down the road have worked out to be 12% of the daily infections number. That means the number of new hospitalizations resulting from Tuesday’s new case count will be 1,839. The number of new hospitalizations resulting from Saturday’s new cases will be 1,853 in two weeks. According to Gov. Gavin Newsom, 44,369 of the state’s 73,867 hospital beds were occupied on Monday. That seems like a good cushion, but even just a week of new admissions in the range of 1,800 is another 12,600 beds occupied. Two weeks at that rate is another 25,200 beds taken up. Adding that to the Monday’s total would have about 70,000 of the state’s 73,867 beds full. And those are just Covid-19 cases. That number does not account for the state’s usual daily demand due to other maladies. Test positivity rates present more evidence of the state’s crisis. In the past week, California is delivering far more tests per day than it ever has, yet the positivity rate continues to grow. That means the actual number of infections in the population is growing. The 14-day test positivity rate is now 5.9%. That’s up 2% over the past two weeks. California has 40 million residents. A 2% jump in infections in a population that size could represent up to 800,000 additional cases. Despite pleas from state and local officials urging residents not to travel for Thanksgiving due to the coronavirus, millions of Southern Californians are still expected to do just that, with this afternoon anticipated to be the busiest time on Southland freeways. The Automobile Club of Southern California estimated that 3.86 million Southern California residents will be traveling for the holiday weekend, a 13% drop from last year. Health authorities have been recommending against travel this Thanksgiving due to surging COVID-19 cases. The state has issued a travel advisory, urging people who do travel to quarantine for 14 days upon their return. Travelers coming through Los Angeles International and Van Nuys airports and Union Station beginning Wednesday will be required to sign a form acknowledging California’s recommended 14-day self quarantine in response to rising coronavirus rates. During a Monday briefing, Mayor Eric Garcetti urged people to not travel over the Thanksgiving holiday, not even to go across town because of how widespread Covid-19 cases have been recently.

Nick Note: how is this going to work. You cannot get them to isolate or even wear a mask. And now you are going to get them to voluntarily isolate. This is going to end up in the slaughter of baby Boomers

The AstraZeneca Covid Vaccine Data Isn’t Up to Snuff

There were other dosing issues, too, that haven’t been explained even though dosing is the centerpiece of the press release. There are many different regimens in these trials—the UK study has more than two dozen arms, meaning the volunteers were divided into that many groups according to age and how much of the vaccine would be administered and when. The doses are measured by the number of altered viral particles they contain, and the developers decided that the standard dose would be 5 x 1010 viral particles. But for many of those arms in the UK trial—as well as everyone who got the vaccine in the Brazilian trial—publicly available trial information shows that the standard dose could be between 3.5 and 6.5 × 1010 viral particles. The lower end of that range isn’t far off from a half-dose. How did Oxford-AstraZeneca end up with this patched-together analysis instead of data from a single, large trial? After all, this vaccine went into Phase 3 testing before either BNT-PFizer’s or Moderna’s did. But in the UK, where that testing started, the Covid-19 outbreak happened to be receding. That meant results would be coming in very slowly. A month later, a second Phase 3 trial for the vaccine started in Brazil. That one was for healthcare workers, for whom the risk of being exposed to Covid was far higher than it was for the people in the UK trial. But the two trials had other substantive differences. In the UK, for example, the volunteers who did not get the experimental Covid vaccine were injected with meningococcal vaccine; in Brazil, those in the comparison group were given a saline injection as a placebo. Meanwhile, BNT-Pfizer and Moderna began Phase 3 trials for their coronavirus vaccines on the same day in July: Both planned to include 30,000 volunteers at the time, and both trial plans were approved by the FDA. Oxford-AstraZeneca then announced they, too, would run a 30,000-person trial in the US. But that research on the Oxford-AstraZeneca vaccine quickly fell behind the others’. The US trial was approved by the FDA, but it didn’t start recruiting people until the end of August; and just a week later, it was put on hold so the FDA could investigate a serious adverse event in the UK trial. It wasn’t clear what caused the volunteer to get sick, but the FDA did not give the all-clear for Oxford-AstraZeneca’s US trial to resume until Oct. 23. By then the protocol for the trial had been publicly released. It says the plan is to inject the vaccine in two standard doses, a month apart; and two people will be vaccinated for every one who gets a placebo saline injection. So here we are at the end of November. BNT-Pfizer and Moderna have offered up a masterclass in how to do major vaccine trials quickly in a pandemic, while Oxford-AstraZeneca has, for the moment, only an assortment of smaller ones ready to look at. But wait, more red flags! Last week, Oxford-AstraZeneca published some results from earlier in the development of the UK trial. That paper included a trial protocol for the UK study, attached as an appendix.

Deep in that document, and apparently overlooked by reporters and commentators, was an eyebrow-raising suggestion: Under a section marked “Interim and primary analyses of the primary outcome,” the trialists outline a plan to combine and analyze data from four clinical trials (only half of which are Phase 3), carried out in different ways on three different continents.

The plan, they wrote, was to pull out results only for the people across these four trials who had gotten “two standard-dose vaccines,” and then pool those together for what’s called a meta-analysis. Nick Note: I am reading ALL the studies as they are released. To say the least they are very rushed and the lack to me credibility. Why am i doing this. Well the great white hope for the world economy is stopping this killer virus. And it is killing more and more people each and every day. So what ever they are doing its not working. The stock market is in one of its biggest mindless rally ever. (Thats how i make my money! ) A rally based on self serving headlines and political spinwill always end in disaster. Based on headlines THEY DROVE THE MARKETS TO RECORD HIGHS IN THE MIDDLE OF A DEPRESSION NO ONE ADMITS WE ARE IN. Its like trading support and resistance lines or Gann Fans it sounds good but does not work . I wish it was that easy. My analysis is the virus is far from beaten and these 6 month wonder drugs are not all they are cracked up to be.. Their is no vaccine and if one of these happens to work it will take 2 years before this shit is over. See the Lancet Study below….. It makes great reading:

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine

Nick Bit: One of member who was involved in clinical studies told me his boss said the following:

“If you torture the data enough it will confess to anything”

This is the most tortured data i have ever seen

Unemployment Claims Are Rising Again Amid Covid-19 Surge

Weekly jobless claims ticked up for the second week in a row to 778,000 (on a seasonally adjusted basis), significantly more than the 733,000 claims experts were expecting—the data is a discouraging sign that the record-breaking surge in Covid-19 cases is beginning to impact the labor market.

Lawmakers in Washington have so far been unable to agree on another tranche of federal aid, despite a consensus among policymakers and experts that more stimulus is necessary to prop up the economy during the winter months before a coronavirus vaccine becomes widely available. Another 311,675 people filed claims through the Pandemic Unemployment Assistance program last week, which covers people not eligible for traditional state benefits like freelancers and gig workers.

20.5 million. That’s how many people received some form of government unemployment benefit last week. A recent report from the Century Foundation showed that when the Pandemic Unemployment Assistance Program and another emergency unemployment aid program expire at the end of December, 12 million people will lose benefits. Coronavirus cases continue to surge in the United States ahead of the holiday season. Two million cases were reported in a span of just two weeks, the New York Times reported, and more states and cities are imposing new restrictions to curb the spread of the virus. Nick Note: As the virus spreads the economy will suck shut again. After the No Thanks giving major super spreader event the shutdowns will only get worse. Then you got Christmases and many people will not me able to say NO.  And that means the worst will hit in January and February, And lockdowns will be enforced from one end of the country to the other. And vaccinations just STARTING by then will do nothing. Sooner or later the enormity of the double dip recession will be apparent to all. kicking and screaming along the way the stock market will empty the pockets of another group of suckers as it crashes!

Airlines stir doubts among health experts with claims of safe flying

Airlines have loudly insisted that it’s safe to fly during the coronavirus pandemic, and U.S. travel is surging before the Thanksgiving holiday despite a nationwide spike in virus cases.

Yet top U.S. infectious-disease experts say the findings underpinning the carriers’ safety claims aren’t that conclusive.

Concerned about the “misinterpretation” of their findings, researchers on a Defense Department study that has been widely cited by the industry added a cautionary revision.

A senior expert in travel-health issues declined to participate in an airline trade group’s news conference, citing what he called their “bad math.”

“The airline industry got a little ahead of itself trying to say the risk is zero,” said David Freedman, a University of Alabama at Birmingham professor emeritus who balked at appearing with an International Air Transport Association event that cited his work. U.S. airlines, hit with an unprecedented drop in demand since the virus began spreading widely in March, are enjoying their strongest week since then. Even as health officials warn against travel during the Thanksgiving holiday because of a surge in covid-19 cases, more than 4 million people traversed airports between Friday and Monday. The risk of being infected with the novel coronavirus on planes, which have highly effective filters that remove virus from the air and where mask usage is required, is probably fairly low, scientists say.

But the research is far from clear and some recent cases have documented transmission on flights even when passengers wore masks and sat far apart, according to a review of recent cases and interviews with academics and disease specialists.

“I definitely can say it’s premature to say that air travel is very safe,” said Qingyan Chen, an engineering professor at Purdue University in Indiana who’s written extensively on disease transmission on planes. Airline officials, responding to the historic drop in passengers, repeatedly have defended the protections against infection on flights. “Flying is safe,” Nicholas Calio, president of Airlines for America, a trade group for large carriers, said at a Nov. 12 briefing. “I will state that categorically.” A4A declined to add additional comments. It has highlighted the efforts to force passengers to wear masks and to remain apart during boarding and exiting, and to disinfect aircraft. Montreal-based IATA defended its use of Freedman’s data on confirmed in-flight transmissions, saying it never characterized the results as definitive. A4A frequently has cited a study by the Harvard T.H. Chan School of Public Health, which was funded by the trade group and other aviation industry sources, that concluded the risk of transmission on an airliner was “very low.” But authors cautioned that their projections depended on adherence to mask usage and they also urged airlines to improve ventilation while planes are parked at the gate. Another study airlines point to was conducted by the Defense Department with the assistance of United Airlines Holdings Inc. and Boeing Co. It attempted to measure how aerosol virus particles were exhaled by a simulated masked passenger. United said in promotional materials released Oct. 15 the study “determined the risk is almost nonexistent.”

However, after news coverage of the study, the authors added a revision, saying they were “concerned about the potential misinterpretation of the findings.” They also acknowledged they based their results on a person exhaling relatively few virus particles, an amount well below levels documented in some cases.

The airplane filters and mask usage “significantly reduces” exposure to infectious aerosols, they wrote. “However, the current established scientific understanding of SARS-CoV-2 transmission dynamics is not sufficient to calculate definitive SARS-CoV-2 transmission risk from these measurements of aerosol transport The U.S. Centers for Disease Control summarizes the risks from air travel this way on its website: “Most viruses and other germs do not spread easily on flights because of how air circulates and is filtered on airplanes. However, keeping your distance is difficult on crowded flights, and sitting within six feet of others, sometimes for hours, may increase your risk of getting covid-19.” Purdue’s Chen said he’s been following news reports in China of possible infection between passengers on a Nov. 9 Air China flight from Los Angeles to Tianjin. Ten people who weren’t connected to one another and resided in different parts of the U.S. tested positive for the coronavirus after arrival. All the passengers had tested negative for the disease before the flight, suggesting at least some of the transmission occurred on the plane, he said.

Such incidents are confounding because they seem to contradict Chen’s own earlier research showing mask usage can dramatically lower risks of infection, he said.

“That’s why I’m having doubts about what’s going on in airplanes,” he said. Government researchers in Ireland documented as many as 13 cases linked to a single flight last summer, according to a paper published in October. The infections in five of the cases were genetically linked, “strongly suggesting a single point source of infection,” the authors said. The widebody jet was largely empty, people were spaced out on the plane and almost everyone whose activity could be documented said they wore masks. Nevertheless, the authors estimated that 10-18% of passengers became infected. “It is interesting that four of the flight cases were not seated next to any other positive case, had no contact in the transit lounge, wore face masks in-flight and would not be deemed close contacts under current guidance from the European Centre for Disease Prevention and Control,” the authors said. Nick Note: Proof your  stupid is you get on a airplane with your N95 joke toilet paper mask in hand. You fly you die or you give the gift that keeps on giving. The deadest plague in 100 years. People is it worth the risk?

Dow closes above 30,000 for the first time in history

The Dow Jones Industrial Average hit a record high of 30,000 on Tuesday, a symbolically significant benchmark in a year that has been whipsawed by the economic fallout of the coronavirus pandemic and a bruising election cycle.

The Dow rose by over 450 points to close the day at 30,045, a record high for the blue-chip index. The S&P 500 and the Nasdaq Composite both climbed by around 1.5 percent.

Wall Street’s rally came a day after the Trump administration agreed to start the transition process to President-elect Joe Biden, giving him access to millions of dollars in federal funds and other resources to begin his transition to power.

The transition process had been stalled for weeks as President Donald Trump’s team waged a sputtering legal battle across the country to contest the results, leaving Biden out of the loop on the Covid-19 vaccine and other key issues.

Trump, who is facing mounting pressure to publicly concede, cheered the stock market rally Tuesday, telling reporters in the White House briefing room he wanted to “congratulate the people of our country because there are no people like you,” and called the Dow’s milestone a “sacred number.” Markets hit record highs this month after Moderna and Pfizer both announced promising vaccine candidates in the fight against Covid-19. Wall Street was also optimistic after former Federal Reserve Chair Janet Yellen emerged as President-elect Joe Biden’s likely pick for treasury secretary. While Yellen faces a huge challenge to lead the country out of the pandemic amid millions of lost jobs and record debt levels, markets soared under her tenure at the Fed and she has decades of macroeconomic experience. During her four-year tenure at the Fed, Yellen supported the economic recovery through accommodative monetary policy and support for low interest rates.

In July, Yellen urged lawmakers to renew the emergency benefits created in the early days of the pandemic, telling members of the House Select Subcommittee on the Coronavirus Crisis that it would be “a catastrophe” not to extend the $600 in additional weekly unemployment insurance for millions of out-of-work Americans. The additional benefits are a lifeline for those who are out of work, Yellen said, adding that, on a broader spectrum, “We need the spending that those unemployed workers can do.”

This market benchmark has been a long time coming. The Dow came within a few percentage points of hitting 30,000 back in January, a window of opportunity that seemed to slam shut when the Covid-19 pandemic led to widespread shutdowns, job losses and plunging gross domestic product. But aggressive rate cuts by the Federal Reserve and tech sector optimism had buoyed stocks, and the central bank’s interventions were accompanied by a run-up in the valuations of the big tech companies that increasingly dominate the benchmark indices, many of which benefitted from the abrupt and dramatic changes in consumer behavior triggered by the pandemic. “Anytime you have an accommodating Fed, low interest rates, more of an accommodative environment, the prospects are good for stocks,” said David Frisch, president of Frisch Financial Group. “Because of what’s transpired since March, a lot more of us are working from home, we’re doing things virtually, we’re streaming content online and ordering things to come to our homes,” said Sameer Samana, senior global market strategist at Wells Fargo Investment Institute. In particular, Apple, Microsoft and Salesforce have helped propel the Dow higher. There also is an emotional dynamic that comes into play when markets near symbolic benchmarks. “There tends to be a bit of psychology and a market sentiment attached to some of those big levels,” said Yung-Yu Ma, chief investment strategist at BMO Wealth Management.

Analysts say investors should be wary of over-exuberance, given that it still could be months before a vaccine is readily available for most Americans.

“Even with the promise of an effective Covid-19 vaccine, we now have to take a sober look at the damage this virus has caused the economy,” said James McDonald, CEO of Hercules Investments, adding that a “return to normalcy” wouldn’t come right away. “An overnight recovery is impossible, let alone overnight growth that exceeds pre-Covid-19 level. Nick Note: For the record this is the biggest retail ma and pa Holkem retail rallie I have ever seen, It will end in treas…….

Trump: GSA does not determine next president

https://youtu.be/Je1jcG9dElE

President Donald Trump on Tuesday defended his decision to allow the General Services Administration (GSA) to coordinate with former Vice President Joe Biden for a transition of power. “Remember, the GSA has been terrific, and Emily Murphy has done a great job, but the GSA does not determine who the next President of the United States will be,” Trump wrote on Twitter.

Trump said Monday evening he would allow GSA Administrator Emily Murphy to begin the initial steps for a transition of power to Biden after she received a series of threats from angry Biden supporters. “She has been harassed, threatened, and abused — and I do not want to see this happen to her, her family, or employees of GSA,” Trump said. The GSA released $6,300,000 in funds for Biden’s team to begin the transition of power. Establishment media and political figures celebrated the news of Trump’s decision as a sign he was moving to concede the 2020 election despite an ongoing legal challenge. The Biden team also celebrated the news in a statement, asserting that the GSA administrator had “ascertained” that they were “the apparent winners of the election.” “Today’s decision is a needed step to begin tackling the challenges facing our nation, including getting the pandemic under control and our economy back on track,” Biden-Harris Transition Executive Director Yohannes Abraham said in a statement. Nick Note: Trump chances of a Hail Mary working get less and less by the day. Everyone knows that the surprise is if he gets to stay. In spite of the spin the markets priced in a long time ago a Biden administration…..

Thanksgiving could be make-or-break in US virus response

In Pennsylvania, if you’re having friends over to socialize, you’re supposed to wear a mask — and so are your friends. That’s the rule, but Barb Chestnut has no intention of following it.

“No one is going to tell me what I can or not do in my own home” said Chestnut, 60, of Shippensburg. “They do not pay my bills and they are not going to tell me what to do.”

As governors and mayors grapple with an out-of-control pandemic, they are ratcheting up mask mandates and imposing restrictions on small indoor gatherings, which have been blamed for accelerating the spread of the coronavirus. But while such measures carry the weight of law, they are, in practical terms, unenforceable, and officials are banking on voluntary compliance instead. While many are undoubtedly heeding public health advice — downsizing Thanksgiving plans, avoiding get-togethers, wearing masks when they’re around people who don’t live with them — it’s inevitable that a segment of the population will blow off new state and local restrictions and socialize anyway. Experts say that could put greater stress on overburdened hospitals and lead to an even bigger spike in sickness and death over the holidays

“When this started in early March, we weren’t staring at Thanksgiving and Christmas, and we didn’t have the disease reservoir that we have. And that, to me, is the biggest concern in the next few weeks,” said Dr. David Rubin, the director of PolicyLab at Children’s Hospital of Philadelphia. He called the risk of a Thanksgiving spike “extremely high.”

“I think you’re seeing a lot of resistance here,” Rubin said. “I can’t speculate on what people are going to do, but I can say that to the degree that there isn’t a collective buy-in here, it sort of blunts the impact of the measures themselves.” The nation is averaging 172,000 new virus cases per day, nearly doubling since the end of October, according to Johns Hopkins University. Hospitalizations, deaths and the testing positivity rate are also up sharply as the nation approaches Thanksgiving. In response, elected officials are imposing restrictions that, with some exceptions, fall short of the broad-based stay-at-home orders and business shutdowns seen in the spring. Utah and Vermont have banned all social gatherings. So have local governments in Philadelphia and Dane County, Wisconsin. In Kentucky, no more than eight people from two households are permitted to get together; in Oregon, the gathering limit is six. California has imposed an overnight curfew. More states are requiring masks, including those with GOP governors who have long resisted them. The nation’s top health officials are pleading with Americans to avoid Thanksgiving travel. AAA projects Thanksgiving travel will fall by at least 10%, which would be the steepest one-year plunge since the Great Recession in 2008. But that still means tens of millions of people on the road. On social media, people defiantly talk about their Thanksgiving plans, arguing that nothing will stop them from seeing friends and family.

More than 1 million people thronged U.S. airports on Sunday, according to the Transportation Security Administration — the highest number since the beginning of the pandemic.

Dr. Debra Bogen, the health director for Allegheny County, Pennsylvania, which includes Pittsburgh, said that too many have been ignoring public health guidance and that the result has been unchecked spread of the virus. “For the past few weeks, I’ve asked people to follow the rules, curtail gatherings and parties, stay home except for essentials, and wear masks. I’m done asking,” Bogen said at a news conference, her frustration palpable. She announced a stay-at-home advisory that she said would turn into an order if people didn’t comply.

Some people are underestimating the risk to themselves and their friends and families, said Baruch Fischhoff, a Carnegie Mellon University psychologist who has written about COVID-19 risk analysis and communications. Others doubt what health officials are telling them about the virus. And still others are simply irresponsible.

Fischhoff said the lack of a cohesive national pandemic strategy; patchwork and seemingly arbitrary restrictions at the state and local level; and ineffective, politicized and contradictory public health messaging have sown confusion and mistrust. “It has been a colossal, tragic failure of leadership from the very beginning that we didn’t find the common ground in which we were working to protect the weakest among us. And once you’ve lost that coordination, you’re scrambling to get it back and that’s the tragic mess that we’re in now,” he said. In upstate New York, some sheriffs say they have no intention of enforcing Democratic Gov. Andrew Cuomo’s recent mandate barring private gatherings of more than 10 people. Nick Note: If people have a thanksgiving for christmass they will be burring the vulnerable. DO NOT DO IT…… FUCK  thanksgiving!

Global stocks are vulnerable to $300 billion of outflows by year-end, JPMorgan says

 

  • According to JPMorgan, there’s a potential $300 billion headwind that could weigh on global stocks into year-end: portfolio rebalancing.
  • The fourth quarter rally in stocks would likely trigger the balanced mutual fund universe to sell stocks and buy bonds as they rebalance to their 60/40 stock and bond target allocation.
  • $160 billion in stocks are likely subject to being sold by the end of this year, and an additional $150 billion could be sold if the stock market continues to rally into December, JPMorgan said.
  • Visit Business Insider’s homepage for more stories.

Global stocks face a potential $300 billion headwind heading into year-end: portfolio rebalancing. That’s according to a Friday note from JPMorgan, which argued that the strong rally in stocks in the fourth quarter will trigger $160 billion in equity outflows as balanced mutual funds sell stocks and buy bonds to get back to their target allocation of 60% stocks and 40% bonds. And if stocks continue to rally into December, that would likely trigger an additional $150 billion in stock selling by pension funds that tend to rebalance on a quarterly basis, according to the note. JPMorgan based its calculations off of quarter and month-to-date performance, and assumed that the balanced mutual funds were fully rebalanced at its target allocation at the end of October, rather than being underweight stocks. The targeted portfolios included in JPMorgan’s analysis include balanced mutual funds and US defined benefit pension plans. Balanced mutual funds alone represent a $7 trillion universe, according to JPMorgan. “There would be some vulnerability in equity markets in the near term from balanced mutual funds having to sell equities to revert to their 60/40 equity/bond target allocation, either by the end of November or by the end of December at the latest,” JPMorgan said.

Health officials make their final pleas for holiday caution as coronavirus cases spike

WASHINGTON – With nationwide coronavirus hospitalizations topping 80,000 and case counts on the cusp of 200,000 a day, officials and experts are giving their final pleas for caution in the days before Thanksgiving.

Average cases reported each day in the United States have jumped nearly 15% in a week, according to data tracked by The Washington Post. Deaths are also on the rise, with some communities overwhelmed by the bodies

– in El Paso County, Texas, the National Guard was called in to help the morgues. With the holiday travel rush underway, public health leaders warned this weekend that “herd immunity” from promising vaccines remains months away and that every American’s choices this week will shape the country’s virus trajectory. In an interview on CBS News’s “Face the Nation,” Anthony Fauci, the nation’s top infectious-disease expert, said he understands that many Americans are experiencing “covid fatigue” after months of pandemic restrictions, now tightening again in many parts of the country. But traveling over the holidays and ignoring public health guidelines are “going to get us into even more trouble than we’re in right now,” he said. Moncef Slaoui, chief scientific adviser to the White House’s Operation Warp Speed vaccine effort, said on CNN’s “State of the Union” that about 70% of the American population will need to be vaccinated for true herd immunity to occur. That will probably happen around May, he said, based on health officials’ current plans. “Most people need to be immunized before we can go back to a normal life,” he said. Some the front lines of the country’s pandemic response are not sure that months of messaging have gotten through to the public, however.

The Centers for Disease Control and Prevention advised Americans against Thanksgiving travel and get-togethers just days ago, when many people’s plans were already set.

“Absolutely not,” said Utah physician Sean Callahan when asked whether the urgency of the country’s situation has sunk in. He said soaring cases are already straining the quality of care at the University of Utah, where he works in one of the hospital’s intensive-care units and is an assistant professor of pulmonary and critical care. His own message for people is about more than Thanksgiving plans. Callahan said he is concerned that nurses and physicians are already being asked to treat patients outside their usual areas of expertise. He thinks the problem will worsen. “I’m worried that we are going to be asking a lot of providers to do things that are probably outside of their comfort zone, and care is going to suffer, because we’re stretched and doing things we should not be doing,” he said in an interview Sunday. The pressure on health-care resources has spurred leaders nationwide into action. Utah Gov. Gary Herbert, a Republican, said this month that he was mandating face coverings statewide in public settings and for people within six feet of anyone outside their household. (The mandate does not apply to houses of worship.) The reversal, following months of reluctance, came after hospitals warned that they may have to ration care. Nevada Gov. Sisolak, a Democrat, on Sunday announced a “statewide pause” of at least three weeks starting Tuesday, with stricter capacity limits for many businesses, a decreased limit on gatherings and a more extensive mask mandate. Sisolak said people must wear face coverings even in private settings when they are around people outside their household. Ten percent of Nevada’s coronavirus cases were reported in the past week, he said, warning that hospitals could become overwhelmed. “You saw it in New York, you can see it in El Paso right now,” he said. “This can’t become our reality.” Los Angeles County, home to 10 million people, also announced new restrictions Sunday, ordering restaurants and bars to shift to takeout, drive-through and delivery only. As the alarms about hospital capacity mount, holiday travel and gatherings threaten to make health-care workers’ jobs even harder. Now holiday travel and gatherings threaten to make health-care workers’ tasks even harder. “If you look at the map of spread across the country, you can see the risk; it’s very visible. And moving through airports or travel hubs, I think that will increase people’s risk,” Tom Inglesby, director of the Johns Hopkins Center for Health Security, said on “Fox News Sunday.” “Even if they’re driving from point to point, unfortunately, we don’t know if we’re infected when we walk into a gathering.” He referred to recent data released by the CDC that said most infections are spread by people with no symptoms. “The message for everyone is: You can’t assume you don’t have the virus, and you can’t assume the people whose homes you’re about to enter don’t have the virus at this point in our pandemic,” Inglesby said. For those who plan to travel and be with others for the holiday, he recommended keeping gatherings small, spending as much time outdoors as possible, keeping mealtimes short, wearing masks indoors and removing masks only while eating.

More than 1 million people went through Transportation Security Administration checkpoints in airports nationwide on Friday, according to data released daily by the agency, and more than 980,000 travelers were screened Saturday. The number of travelers screened Friday was the second-highest single-day rush since March 16. In an interview aired on NBC News’s “Meet the Press,” Fauci was full of optimism about a vaccine but emphasized the virus’s continued threat.

“Traditionally and historically, highly efficacious and effective vaccines have crushed epidemics like smallpox and polio and measles,” Fauci told NBC’s “Meet the Press.” “We can do that with the vaccines that are going to be coming online. So we should make them be . . . an incentive to have us double down even more with public health measures until we get the full component of the help that’s on its way.” Pfizer filed for emergency authorization for its vaccine Friday. The FDA has announced that a committee of external advisers will meet Dec. 10 to make recommendations to the agency on whether to authorize Pfizer’s vaccine. Slaoui said the advisers will meet Dec. 17 to review the shot developed by Moderna, which has not filed for clearance for its vaccine. Officials’ calls to heed public health guidelines came as two more members of Congress, Rep. Joe Courtney, D-Conn., and Rep. Bryan Steil, R-Wis., said Sunday that they tested positive for the coronavirus after experiencing mild symptoms and are isolating. Nick Note: You are being sold a bill of goods. Do you know how long it took to wipe out Polio: The Salk vaccine was developed in the 1950’s  it was not until  1961 that the infectious transmittal of the disease was stopped. AND Small Pocks?  The disease peeked in the 1950’s and was widespread until l 1966.  It took 16 years to get it under controls. Now they want you to believe they will get the far more contagious coronavirus under control in 5 months using vaccines that have not been approved never mind mass vaccinations have not even begun……. YET… YEAH RIGHT!!